APA (7th ed.) Citation

Sonoyama, T., Shimizu, R., Kubota, R., Matsuo, Y., Okutsu, D., Yamanaka, H., . . . Motomiya, T. (2023). Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial. Neuropsychopharmacology Reports, 43(3), 346. https://doi.org/10.1002/npr2.12359

Chicago Style (17th ed.) Citation

Sonoyama, Takuhiro, Ryosuke Shimizu, Ryuji Kubota, Yumiko Matsuo, Daiki Okutsu, Hideki Yamanaka, Keiko Takasu, Koichi Ogawa, and Tomoko Motomiya. "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Zuranolone in Japanese and White Healthy Subjects: A Phase 1 Clinical Trial." Neuropsychopharmacology Reports 43, no. 3 (2023): 346. https://doi.org/10.1002/npr2.12359.

MLA (9th ed.) Citation

Sonoyama, Takuhiro, et al. "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Zuranolone in Japanese and White Healthy Subjects: A Phase 1 Clinical Trial." Neuropsychopharmacology Reports, vol. 43, no. 3, 2023, p. 346, https://doi.org/10.1002/npr2.12359.